Bank of New York Mellon Corp - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$239,000
-2.4%
300,0000.0%0.00%
Q3 2020$245,000
-74.7%
300,000
-77.0%
0.00%
Q2 2020$967,000
-8.7%
1,304,0000.0%0.00%
Q1 2020$1,059,000
+15.6%
1,304,000
+44.2%
0.00%
Q4 2019$916,000
+17.9%
904,0000.0%0.00%
Q3 2019$777,000
+44.2%
904,000
+49.7%
0.00%
Q2 2019$539,000
-9.4%
604,0000.0%0.00%
Q1 2019$595,000
+9.2%
604,000
+0.7%
0.00%
Q4 2018$545,000
-45.9%
600,000
-40.0%
0.00%
Q3 2018$1,008,000
+21.4%
1,000,0000.0%0.00%
Q2 2018$830,000
+3.0%
1,000,0000.0%0.00%
Q1 2018$806,000
-0.5%
1,000,0000.0%0.00%
Q4 2017$810,000
+3.1%
1,000,0000.0%0.00%
Q3 2017$786,000
-27.3%
1,000,000
-9.1%
0.00%
Q2 2017$1,081,000
+5.1%
1,100,0000.0%0.00%
Q1 2017$1,029,000
+3.7%
1,100,0000.0%0.00%
Q4 2016$992,000
+153.1%
1,100,000
+214.3%
0.00%
Q3 2016$392,000350,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$56,098,0001.12%
L & S Advisors Inc 795,000$767,0000.14%
OAKTREE CAPITAL MANAGEMENT LP 9,964,000$9,690,0000.11%
WEDBUSH SECURITIES INC 13,000$1,251,0000.07%
Kohlberg Kravis Roberts & Co. L.P. 3,163,000$3,076,0000.06%
ZAZOVE ASSOCIATES LLC 246,000$240,0000.02%
Balboa Wealth Partners 21,000$200.01%
Russell Investments Group, Ltd. 1,910,000$1,875,0000.00%
GAMCO INVESTORS, INC. ET AL 250,000$244,0000.00%
Regal Investment Advisors LLC 20,000$19,0000.00%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders